Helicobacter pylori gastritis, the unifying concept for gastric diseases

Helicobacter

Volumn 12, Issue SUPPL. 2, 2007, Pages 39-44

  Egan, Brian J ^a   Holmes, Kate ^a   O'Connor, Humphrey J ^a   O'Morain, Colm A ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Atrophic gastritis; Biomarkers; Corpus gastritis; Gastric acid

Indexed keywords

BIOLOGICAL MARKER;

ACID SECRETION; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CANCER RISK; DISEASE SEVERITY; GASTRITIS; HELICOBACTER PYLORI; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; STOMACH CANCER;

GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 35948977756     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00575.x     Document Type: Review

References (39)

1. Marshall BJ Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983 8336 : 1273 5.
2. Graham DY SJ. Helicobacter pylori. In : Feldman M, ed. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 8th edn. Saunders, Philadelphia, PA, 2006 1049 68.
3. Rugge M, Correa P, Dixon MF, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002 16 : 1249 59.
4. Webb PM, Knight T, Greaves S, Wilson A, Newell DG, Elder J, Forman D. Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. BMJ 1994 308 : 750 3.
5. Robinson K, Argent RH, Atherton JC. The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 2007 21 : 237 59.
6. Graham DY. Community acquired acute Helicobacter pylori gastritis. J Gastroenterol Hepatol 2000 15 : 1353 5.
7. Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol 1988 83 : 504 9.
8. Sepulveda AR, Graham DY. Role of Helicobacter pylori in gastric carcinogenesis. Gastroenterol Clin North Am 2002 31 : 517 35.
9. Egan BJ, OMorain CA. A historical perspective on Helicobacter gastroduodenitis and its complications. Best Pract Res Clin Gastroenterol 2007 21 : 335 47.
10. Soybel DI. Anatomy and physiology of the stomach. Surg Clin North Am 2005 85 : 875 94.
11. Liu Y, Akiyama J, Graham DY. Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease. Minerva Gastroenterol Dietol 2006 52 : 235 48.
12. Liu Y, Vosmaer GD, Tytgat GN, Xiao SD, Ten Kate FJ. Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis. J Clin Pathol 2005 58 : 927 31.
13. Van Zanten SJ, Dixon MF, Lee A. The gastric transitional zones: neglected links between gastroduodenal pathology and Helicobacter ecology. Gastroenterology 1999 116 : 1217 29.
14. Wyatt JI, Rathbone BJ, Dixon MF, Heatley RV. Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 1987 40 : 841 8.
15. Naylor GM, Gotoda T, Dixon M, Shimoda T, Gatta L, Owen R, Tompkins D, Axon A. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut 2006 55 : 1545 52.
16. Baron JH. Lean body mass, gastric acid and peptic ulcer. Gut 1969 10 : 637 42.
17. Wolfe MM, Nompleggi DJ. Cytokine inhibition of gastric acid secretion - a little goes a long way. Gastroenterology 1992 102 : 2177 8.
18. Ju Choi I, Fujimoto S, Yamauchi K, Graham DY, Yamaoka Y. Helicobacter pylori environmental interactions: effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 production. Cell Microbiol 2007 9 : 2457 69.
19. Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, Flores-Gutierrez JP, Maldonado-Garza HJ, Perez-Perez GI. Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8-251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer 2007 7 : 70.
20. Lee WP, Tai DI, Lan KH, et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res 2005 11 : 6431 41.
21. Ohyauchi M, Imatani A, Yonechi M, et al. The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005 54 : 330 5.
22. Gerhard M, Lehn N, Neumayer N, et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 1999 96 : 12778 83.
23. Peek RM Jr., Thompson SA, Donahue JP, Tham KT, Atherton JC, Blaser MJ, Miller GG. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians 1998 110 : 531 44.
24. Li L, Genta RM, Go MF, Gutierrez O, Kim JG, Graham DY. Helicobacter pylori strain and the pattern of gastritis among first-degree relatives of patients with gastric carcinoma. Helicobacter 2002 7 : 349 55.
25. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999 37 : 2274 9.
26. Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 2005 128 : 833 48.
27. Clyne M, Dillon P, Daly S, O 'Kennedy R, May FE, Westley BR, Drumm B. Helicobacter pylori interacts with the human single-domain trefoil protein TFF1. Proc Natl Acad Sci USA 2004 101 : 7409 14.
28. Hynes SO, Keenan JI, Ferris JA, Annuk H, Moran AP. Lewis epitopes on outer membrane vesicles of relevance to Helicobacter pylori pathogenesis. Helicobacter 2005 10 : 146 56.
29. Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, Graham DY. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007 56 : 631 6.
30. Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007 42 : 2 10.
31. Samloff IM. Pepsinogens, pepsins, and pepsin inhibitors. Gastroenterology 1971 60 : 586 604.
32. Mukoubayashi C, Yanaoka K, Ohata H, Arii K, Tamai H, Oka M, Ichinose M. Serum pepsinogen and gastric cancer screening. Intern Med 2007 46 : 261 6.
33. Borch K, Axelsson CK, Halgreen H, Damkjaer Nielsen MD, Ledin T, Szesci PB. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol 1989 24 : 870 6.
34. Miki K, Ichinose M, Kakei N, et al. The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer. Adv Exp Med Biol 1995 362 : 139 43.
35. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, Doi H, Yoshida H, Kawabe T, Omata M. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005 54 : 764 8.
36. Rehfeld JF, Friis-Hansen L, Goetze JP, Hansen TV. The biology of cholecystokinin and gastrin peptides. Curr Top Med Chem 2007 7 : 1154 65.
37. Coghlan JG, Gilligan D, Humphries H, McKenna D, Dooley C, Sweeney E, Keane C, O'Morain C. Campylobacter pylori and recurrence of duodenal ulcers - a 12-month follow-up study. Lancet 1987 14 : 1109 11.
38. Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer. effect of eradication of Helicobacter pylori. Gut 1993 34 : 888 92.
39. el-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995 109 : 681 91.